Pioneering new therapies for cancer


Prolongation of Survival Results from Phase 2 Clinical Study of Pracinostat and Azacitidine in Acute Myeloid Leukemia (ASH)
Press Release | Presentation

MEI Pharma Hosts Annual Meeting of Stockholders
Dec 1, 2016 | Webcast

MEI Pharma Presents at Stifel Healthcare Conference
Nov 15, 2016 | Webcast | Slides

Formulation Selection and Development for ME-401 (AAPS)
Nov 15, 2016 | Poster

MEI Pharma Reports First Quarter Fiscal Year 2017 Results
Nov 9, 2016 | Press Release